Halozyme Therapeutics: Wells Fargo raises target price to $110 from $95
HALO•Wells Fargo raised its target price for Halozyme Therapeutics to $110 from $95.
Related News
Texas Roadhouse price objective raised to $227 from $225 by BofA Global Research
TXRH•
Marqeta, Inc.: Mizuho raises target price to $20 from $18
MQ•
GRAIL Inc: Mizuho raises target price to $110 from $100
GRAL•
Atmus Q3 sales beat expectations on Koch Filter acquisition; lifts outlook
ATMU•
Microchip Technology: Mizuho cuts target price to $90 from $112
MCHP•